From: Becker's Supply Chain Report <>
Subject: 8 latest FDA approvals | What are US businesses' most pressing supply chain concerns? | NLRB issues labor complaint against CHS | Allergan pays $250M for licensing rights to AstraZeneca's experimental treatment
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

Oct. 5, 2016

1. US businesses' most pressing supply chain concerns: 4 things to know  Full story
3 ways augmented reality devices could improve supply chain  Full story
3. 5 factors driving supply chain innovation  Full story
4. How can you improve your bottom line without impacting patient care? Learn how in this upcoming webinar  
5. Allergan buys licensing rights to AstraZeneca's experimental treatment for $250M 
6. 8 latest FDA approvals 
7. Upcoming webinar: 
Healthcare Hold'em -- 10th Annual ReviveHealth Trust Index Reveals Who's Winning (and Losing) in the Game of Trust  
8. Physicians often overlook medication as treatment option for alcohol abuse  
9. NLRB issues labor complaint against CHS  Full story
10. Supply chain tip of the week: Use data to motivate change 
50 hospitals with innovation programs
Full story 
12. 12 statistics on construction and design: Patient experience is paramount

Call for submissions - "Supply chain tip of the week": If you would like to contribute a tip, insight or best practice related to improving the hospital supply chain, please email Mackenzie Bean at

Contact Us

Editorial Contact: 
Molly Gamble 
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO

Becker's Hospital Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by in collaboration with
Constant Contact